Header Logo

Sarah Hughes

Concepts (112)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Clinical Trials as Topic
6
2014
378
1.330
Why?
Drug Industry
2
2014
40
0.760
Why?
Data Interpretation, Statistical
5
2012
188
0.650
Why?
Dideoxynucleosides
4
2010
8
0.590
Why?
Anti-HIV Agents
4
2012
147
0.550
Why?
Information Dissemination
1
2014
112
0.440
Why?
Postoperative Care
1
2013
98
0.440
Why?
Patient Dropouts
1
2012
47
0.430
Why?
Preoperative Care
1
2013
147
0.420
Why?
Recovery of Function
1
2013
204
0.410
Why?
HLA-B Antigens
2
2008
14
0.400
Why?
Surgical Procedures, Operative
1
2013
145
0.400
Why?
Drug Hypersensitivity
2
2008
23
0.400
Why?
HIV Infections
5
2012
863
0.390
Why?
Aging
1
2013
694
0.300
Why?
Anniversaries and Special Events
1
2007
10
0.300
Why?
Societies, Scientific
1
2007
32
0.290
Why?
Genital Neoplasms, Female
1
2005
19
0.260
Why?
Research Design
3
2012
543
0.210
Why?
Sample Size
2
2012
54
0.190
Why?
History, 20th Century
2
2007
205
0.130
Why?
Humans
14
2014
52894
0.130
Why?
Uterine Cervical Neoplasms
2
2007
140
0.120
Why?
Online Systems
1
2014
21
0.120
Why?
Access to Information
1
2014
29
0.120
Why?
Confidentiality
1
2014
54
0.120
Why?
Research Personnel
1
2014
87
0.110
Why?
Myocardial Infarction
2
2009
805
0.110
Why?
Patient Positioning
1
2013
37
0.110
Why?
Delirium
1
2013
51
0.110
Why?
Pain, Postoperative
1
2013
111
0.100
Why?
Wound Healing
1
2013
152
0.100
Why?
Government Agencies
1
2011
7
0.100
Why?
Pain Management
1
2013
129
0.100
Why?
Venous Thromboembolism
1
2013
152
0.100
Why?
Lamivudine
1
2010
7
0.100
Why?
Drug and Narcotic Control
1
2011
27
0.100
Why?
Organophosphonates
1
2010
21
0.100
Why?
Deoxycytidine
1
2010
29
0.100
Why?
Cooperative Behavior
1
2012
209
0.100
Why?
Adenine
1
2010
39
0.090
Why?
Patient Compliance
1
2012
336
0.090
Why?
Patient Discharge
1
2013
442
0.090
Why?
Bone Density
1
2010
173
0.090
Why?
Angioplasty, Balloon, Coronary
1
2009
130
0.080
Why?
Expert Testimony
1
2008
28
0.080
Why?
Drug Approval
1
2008
27
0.080
Why?
Thrombolytic Therapy
1
2009
150
0.080
Why?
Risk Factors
3
2013
4473
0.080
Why?
Statistics as Topic
1
2009
144
0.080
Why?
Fibrinolytic Agents
1
2009
143
0.080
Why?
Patch Tests
1
2008
11
0.080
Why?
Pharmacogenetics
1
2008
21
0.080
Why?
Reverse Transcriptase Inhibitors
1
2008
29
0.080
Why?
Genetic Testing
1
2008
102
0.080
Why?
Models, Theoretical
1
2009
249
0.070
Why?
Decision Support Techniques
1
2009
154
0.070
Why?
Aged
5
2013
11572
0.070
Why?
History, 21st Century
1
2007
139
0.070
Why?
Pelvic Exenteration
1
2005
1
0.070
Why?
Papillomavirus Vaccines
1
2007
65
0.070
Why?
Vulvar Neoplasms
1
2005
10
0.070
Why?
Female
7
2013
27502
0.070
Why?
Lymph Node Excision
1
2005
32
0.070
Why?
History, 19th Century
1
2005
55
0.070
Why?
Lymphatic Metastasis
1
2005
67
0.070
Why?
Sentinel Lymph Node Biopsy
1
2005
40
0.070
Why?
Papillomavirus Infections
1
2007
105
0.060
Why?
Hysterectomy
1
2005
66
0.060
Why?
Endometrial Neoplasms
1
2005
53
0.060
Why?
Neoplasm Invasiveness
1
2005
211
0.060
Why?
Combined Modality Therapy
1
2005
295
0.060
Why?
Ovarian Neoplasms
1
2005
120
0.060
Why?
Periodicals as Topic
1
2007
160
0.060
Why?
Neoplasm Staging
1
2005
412
0.060
Why?
Risk Assessment
1
2009
1645
0.050
Why?
Sensitivity and Specificity
1
2005
1001
0.050
Why?
Prospective Studies
1
2008
2711
0.050
Why?
Young Adult
3
2010
3820
0.030
Why?
Adolescent
3
2010
5402
0.030
Why?
Middle Aged
4
2010
14051
0.030
Why?
Adult
4
2010
13801
0.030
Why?
European Union
1
2011
10
0.020
Why?
Emtricitabine
1
2010
7
0.020
Why?
Tenofovir
1
2010
8
0.020
Why?
Drug Combinations
1
2010
121
0.020
Why?
Absorptiometry, Photon
1
2010
94
0.020
Why?
Europe
1
2010
150
0.020
Why?
Coronary Restenosis
1
2009
16
0.020
Why?
Male
4
2010
24089
0.020
Why?
United Kingdom
1
2009
52
0.020
Why?
Bone and Bones
1
2010
153
0.020
Why?
Adverse Drug Reaction Reporting Systems
1
2009
46
0.020
Why?
Coronary Angiography
1
2009
132
0.020
Why?
Genetic Markers
1
2008
110
0.020
Why?
Survival Rate
1
2009
665
0.020
Why?
Electrocardiography
1
2009
366
0.020
Why?
Papillomaviridae
1
2007
40
0.020
Why?
Coronary Artery Disease
1
2009
242
0.020
Why?
Double-Blind Method
1
2008
559
0.020
Why?
Antigens, Viral
1
2007
134
0.020
Why?
Genotype
1
2008
575
0.020
Why?
Vaccines, DNA
1
2007
94
0.020
Why?
Receptors, Antigen, T-Cell
1
2007
276
0.020
Why?
Follow-Up Studies
1
2009
1991
0.020
Why?
Dendritic Cells
1
2007
491
0.010
Why?
HIV-1
1
2008
686
0.010
Why?
Time Factors
1
2009
3237
0.010
Why?
Aged, 80 and over
1
2009
4467
0.010
Why?
Treatment Outcome
1
2009
4223
0.010
Why?
Retrospective Studies
1
2009
5142
0.010
Why?
Animals
1
2007
18206
0.010
Why?
Hughes's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (112)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_